• Representing a US pharmaceutical company in connection with a DOJ and SEC investigation of alleged FCPA violations in China.
  • Representing a New York Stock Exchange listed technology company in an internal investigation in Asia and self-disclosure to the DOJ and SEC of alleged FCPA violations.
  • Representing a global pharmaceutical company in an SEC investigation in Southeast Asia.
  • Advising a global life sciences company on various internal investigations, compliance and regulatory matters in China.
  • Conducting numerous internal investigations involving allegations of corruption, bribery and financial fraud for multiple companies in various industries.
  • Advising a global manufacturing company in its pre-acquisition anti-corruption due diligence in Asia.